Products for Research Use Only
RegisterLogin

ENMD-2076

CAT: 0013-GTR19175000-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19175000-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ENMD-2076 is a multi-targeted kinase inhibitor with potent activity against Aurora A, Flt3, VEGFR2/3, FGFR1/2, Src, and PDGFRα. It has demonstrated antitumor efficacy in preclinical models, supporting its investigation in oncology research for cancers dependent on these signaling pathways, including breast and ovarian malignancies.
CAS Number
934353-76-1
Product Name Alternative
Src, RET, PDGFR, VEGFR, VEGFR3/FLT4, Vascular endothelial growth factor receptor, ENMD 2076, ENMD2076, ENMD-2076, Fms like tyrosine kinase 3, Fibroblast growth factor receptor, FGFR, FLT3, Inhibitor, inhibit, Platelet-derived growth factor receptor, CD135, Cluster of differentiation antigen 135, cRET, AuroraKinase, Aurora Kinase, Aurora A, Apoptosis
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.79 mM) ; DMSO:97 mg/mL (258.34 mM) ; H2O:1 mg/mL (2.66 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CN1CCN (CC1) c1cc (Nc2cc (C) [nH]n2) nc (\C=C\c2ccccc2) n1
Molecular Formula
C21H25N7
Molecular Weight
375.47
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19203372-01ENMD-1198
GTR19187605ENMD-1068 hydrochloride
GTR19200333-01ENMD-1068 HBr
GTR19174681-01ENMD-1068 HCl
GTR18987640RIF1 (aa 2076-2089) Immunizing Peptide
GTR17696711Goat anti-RIF1 (aa 2076-2089) Antibody
GTR19177886-01UCL 2077
GTR19199394-01CE-2072
GTR19240903-01DB-2073
GTR19197532-01HI-207

Alternative Products

CatalogName
A4130-200ENMD-2076
MBS132137-01ENMD 2076

Popular Products